-
Posted by
Two Blokes May 16 -
Filed in
Stock
-
5 views
SASKATOON, Saskatchewan--(BUSINESS WIRE)--ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press releases dated May 1 and May 6, 2025, it has closed the second and final tranche (the “Second Tranche”) of its non-brokered private placement (the "Offering") of units of the Com.
